C4 Therapeutics, Inc. · NASDAQ:CCCC
Sirenia Capital Management LP reported a 9.90% stake in C4 Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Sirenia Capital Management LP reported a 9.90% stake in C4 Therapeutics, Inc., 23,505,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 23,505,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sirenia Capital Management LP | 9.90% | 23,505,000 |
| Alex Silverstein | 9.90% | 23,505,000 |
Source
Related
- C4 Therapeutics, Inc.
- Sirenia Capital Management LP
- C4 Therapeutics, Inc. shareholders
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026